The treatment of metastatic uveal melanoma

European Journal of Cancer

Volumn 34, Issue SUPPL. 3, 1998, Pages 27-30

  Pyrhonen S ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Eye neoplasm; Melanoma; Neoplastic metastases; Treatment; Uveal melanoma

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON A; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; DACARBAZINE; FOTEMUSTINE; INTERLEUKIN 2; IODINATED POPPYSEED OIL; LOMUSTINE; RECOMBINANT ALPHA2B INTERFERON; TAMOXIFEN; VINCRISTINE;

ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG RESISTANCE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; PRIORITY JOURNAL; UVEA MELANOMA;

EID: 0344835954     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(97)10161-7     Document Type: Conference Paper

References (29)

1. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991, 36, 161-195.
2. Adams KS, Abrahamson DH, Elsworth RM, et al. Cobalt plaque versus enucleation for uveal melanoma. Comparison of survival rates. Br J Ophthalmol 1988, 72, 494-497.
3. Guthoff R, Frischmuth J, Jensen OA, Bjerrum K, Prause JU. Das aderhautmelanom: eine retrospektive randomisierte vergleichs-studie ruthnium-bestrahlung vs enukleation. Klin Monatsbl Augenheilkd 1992, 200, 257-261.
4. Raivio I. Uveal melanoma in Finland; an epidemiological, clinical, histological and prognostic study. Acta Ophthalmol 1977, 133(Suppl), 4-64.
5. Packard RBS. Pattern of mortality in choroidal malignant melanoma. Br J Ophthalmol 1980, 64, 565-575.
6. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983, 101, 1894-1895.
7. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991, 98, 383-389.
8. Einhorn LH, Burgess MA, Gottlieb JA. Metastatic patterns of choroidal melanoma. Cancer 1974, 34, 1001-1004.
9. Bedikian AY, Kantarjian H, Young SE, Bodey GP. Prognosis in metastatic choroidal melanoma. South Med J 1981, 74, 574-577.
10. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983, 52, 334-336.
11. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993, 72, 2219-2223.
12. Albert DM, Ryan LM, Borden EC. Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis. Arch Ophthalmol 1996, 114, 107-108.
13. Zimmerman LE. Metastatic disease from uveal melanomas. The Bowman lecture: a review of current concepts with comments concerning future research and prevention. Trans Ophthalmol Soc U.K. 1980, 100, 34-54.
14. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135, 807-810.
15. Albert DM, Niffenegger AS, Willson JKV. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 1992, 36, 429-438.
16. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995, 76, 1665-1670.
17. Katato K, Liu PY, Sondak V, Flaherty LE. Survival and response to treatment in patients (PTS) with metastatic melanoma from intraocular primaries (MMIP) on SWOG studies (abstract). Proc Am Soc Clin Oncol 1995, 14, 410.
18. Nathan FE, Sato T, Hart E, Berd D, Mastrangelo MJ. Response to combination chemotherapy of liver metastases from choroidal melanoma compared with cutaneous melanoma (abstract). Proc Am Soc Clin Oncol 1994, 13, 394.
19. Albert DM, Ryan LM, Borden EC. Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis. Arch Ophthalmol 1996, 114, 107-108.
20. Mavligit GM, Charnsangavej C, Carrasco CH, Patt YZ, Benjamin RS, Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 1988, 260, 974-976.
21. Sato T, Nathan FE, Berd D, Sullivan K, Mastrangelo MJ. Lack of effect from chemoembolisation for liver metastasis from uveal melanoma (abstract). Proc Am Soc Clin Oncol 1995, 14, 415.
22. Cantore M, Fiorentini G, Aitimi E. Intra-arterial hepatic caboplatin-based chemotherapy for ocular melanoma metastatic to the liver. Report of a phase II study. Tumori 1994, 80, 37-39.
23. Leyvraz S, Spataro V, Bauer J, et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997, 15, 2589-2595.
24. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684. J Clin Oncol 1996, 14, 7-17.
25. Rosenberg SA, Yang JC, Topalian SL, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2. JAMA 1994, 271, 907-913.
26. Pyrhönen S, Hahka-Kemppainen M, Muhonen T. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. J Clin Oncol 1992, 10, 1919-1926.
27. Nathan FE, Berd D, Sato T, et al. BOLD + interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res 1997, 16, 201-208.
28. Dorval T, Fridman A, Mathiof C, Powillard P. Interleukin-2 therapy for metastatic uveal melanoma (abstract). Eur J Cancer 1992, 28A, 2087.
29. Atzpodien J, Hänninen E, Kirchner H. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen. Eur J Cancer 1995, 31 A, 876-881.